Effects of cholecystokinin-B receptor antagonist on dopamine system in tenascin mutant mice

NeuroReport

Volumn 8, Issue 18, 1997, Pages 3919-3922

  Fukamauchi, Fumihiko ^a   Wang, Yi Jun ^a   Mataga, Nobuko ^b   Kusakabe, Moriaki ^c  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^c RIKEN TSUKUBA INSTITUTE   (Japan)

Author keywords

Abnormal behavior; Cholecystokinin (CCK); Dopamine (DA); Mutant mouse; Tenascin (TN); Tyrosine hydroxylase (TH)

Indexed keywords

CHOLECYSTOKININ B RECEPTOR ANTAGONIST; LORGLUMIDE; PD 135158; TENASCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; BRAIN DEVELOPMENT; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; FRONTAL CORTEX; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY;

EID: 0031583909     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199712220-00015     Document Type: Article

References (23)

1. Dourish CT, Rycroft W and Iversen SD. Science 245, 1509-1511 (1989).
2. Wiertelak EP, Maier SF and Watkins LR. Science 256, 830-833 (1992).
3. Harro J, Vasar E and Bradwejn J. Trends Pharmacol 14, 244 249 (1993).
4. Crawley JN. Ann NY Acad Sci 448, 1-8 (1985).
5. Hökfelt T, Rehfeld JF, Skirboll L et al. Nature 285, 476-478 (1980).
6. Wank SA, Pisegna JR and Weerth A. Proc Natl Acad Sci USA 89, 8691-8695 (1992).
7. Honda T, Wada E, Battey JF et al. Mol Cell Neurosd 4, 143-154 (1993).
8. Erickson HP. Curr Opin Cell Biol 5, 869-876 (1993).
9. Steindler DA, Settles D, Erickson HP et al. J Neurosci 15, 1971-1983 (1995).
10. Saga Y, Yagi T, Ikawa Y et al. Genes Dev 6, 1821-1831 (1992).
11. Fukamauchi F, Mataga N, Wang Y-J et al. Biochem Biophys Res Commun 221, 151-156 (1996).
12. Fukamauchi F, Mataga N, Wang Y-J et al. Biochem Biophys Res Commun 231, 356-359 (1997).
13. Watanabe S, Toru M, Ichiyama A et al. J Neurochem 36, 266-275 (1981).
14. Lowry OH, Rosebrough NJ, Farr AL et al. J Biol Chem 193, 265-275 (1951).
15. Tanganelli S, Fuxe K, von Euler G et al. Naunyn Schmiedebergs Arch Pharmacol 342, 300-304 (1990).
16. Tieppo CA, Silva AM, Palermo-Neto J et al. Braz J Med Biol Res 28, 351-354 (1995).
17. Ding XZ and Mocchetti I. Mol Brain Res 12, 77[-]83 (1992).
18. Kihara T, Ikeda M, Ibii N et al. Brain Res 588, 270-276 (1992).
19. Kihara T, Ikeda M, Miyazaki H et al. J Neurochem 61, 1859-1864 (1993).
20. Fukamauchi F, Yoshikawa T, Kaneno S et al. Neuropeptides 10, 207-220 (1987).
21. Bissell MJ, Hall HG and Parry G. J Theor Biol 99, 31-68 (1982).
22. Ben-Zeev A. Trends Biochem Sci 11, 478-481 (1986).
23. Bloomquist BT, Darlington DN, Mains RE et al. J Biol Chem 269, 9113-9122 (1994).